Medicalgorithmics signs contract with US IDTF with estimated revenue potential of up to PLN 46 million over two years. The Agreement covers the provision of specific services and the licensing of Medicalgorithmics’s leading software, DeepRhythmPlatform (DRP), equipped with DeepRhythmAI (DRAI) artificial intelligence algorithms for ECG signal analysis from the Partner’s (IDTF’s) devices.
Medicalgorithmics signs agreement with Samsung spinoff
The Warsaw Stock Exchange-listed Polish medtech company, Medicalgorithmics, has signed an agreement with leading Korean distributor